Management of advanced, resistant Hodgkin's disease and non-Hodgkin's lymphoma: a phase II study.
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D004341:Drug Evaluation; D005047:Etoposide / Q000008:administration & dosage; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D008130:Lomustine / Q000008:administration & dosage; D008171:Lung Diseases / Q000139:chemically induced; D008223:Lymphoma / Q000188:drug therapy*; D008875:Middle Aged
D001761:Bleomycin; D005047:Etoposide; D008130:Lomustine; D002945:Cisplatin; D002955:Leucovorin